In BC with luminal phenotype, P2Y2 activation increases cell migration, not proliferation, by activating the MEK (Mitogen-Activated Protein Kinase Kinase)—ERK1/2 (Extracellular Signal-Regulated Kinases 1 and 2) pathway [104]. The gene discussed is MAPK3; the disease is breast cancer.